Target intelligence / Profile preview

Neuropilin and tolloid-like protein 1 (NETO1)

Target
NETO1
Molecular classification
Auxiliary subunit of ionotropic glutamate receptor complex, Transmembrane protein, Synaptic protein, Other (contains CUB and LDL-receptor class A domains)
01

Overview

Neuropilin and tolloid-like protein 1 (NETO1) is a brain-expressed transmembrane protein containing two extracellular CUB domains and one low-density lipoprotein receptor class A domain. It plays an essential role as an auxiliary subunit of neuronal NMDA receptor (NMDAR) complexes, especially maintaining the abundance of synaptic NR2A-containing NMDARs. NETO1 is primarily localized to the postsynaptic density of excitatory synapses in the brain, where it interacts with core NMDAR subunits and scaffolding proteins such as PSD-95 to regulate synaptic plasticity, cognition, and memory. Loss of NETO1 disrupts synaptic NMDAR composition, reduces long-term potentiation, and impairs learning and memory in animal models. An inherited deficit of synaptic functioning due to NETO1 loss can be pharmacologically rescued (at least in mice) by positive AMPA modulators such as CX546, suggesting both a mechanistic and therapeutic relevance for disease states involving synaptic plasticity deficits[1][2][3][4].

Other names
NETO1BTCL1BCTL1Neuropilin and tolloid like 1Neuropilin and tolloid-like protein 1Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 1Neuropilin (NRP) and tolloid (TLL)-like 1
02

Mechanism of action

Modulators such as CX546 act indirectly by enhancing synaptic NMDAR currents through positive allosteric modulation of AMPA receptors, counteracting synaptic deficits due to NETO1 loss[1]

03

Biological functions

Regulation of synaptic N-methyl-D-aspartate receptor (NMDA receptor) complexesMaintenance of neuronal circuitrySynaptic plasticity regulationSpatial learning and memoryClustering and stabilization of glutamate receptors at synapses
04

Disease associations

Neurodevelopmental disorders (e.g., Developmental and epileptic encephalopathy 76)Synaptic and cognitive dysfunction (as suggested by mouse models)Other (potential implication in neuropsychiatric or cognitive impairment)
05

Safety considerations

No direct safety or toxicity data; potential challenge in targeting auxiliary proteins broadly expressed in CNS without off-target effects or disruption of synaptic function
06

Interacting drugs

CX546 (an ampakine rescue in mouse models)[1]
07

Biomarkers

NETO1 mRNA/protein expression (for neuronal and synaptic health in research)Change in hippocampal NMDA receptor subtype composition in animal models

Beyond the preview

Go deeper on Neuropilin and tolloid-like protein 1 (NETO1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuropilin and tolloid-like protein 1 (NETO1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call